Related Experiment Video

Updated: Sep 27, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Hepatitis B in children

Annemarie L Broderick1, Maureen M Jonas

  • 1Gastroenterology and Nutrition, Division of Gastroenterology, Department of Medicine, Children's Hospital, Boston, Massachusetts, USA.

Seminars in Liver Disease
|March 5, 2003
PubMed

Insights

Childhood hepatitis B virus (HBV) infection poses significant risks, with infants facing a 90% chance of chronic infection. Universal infant vaccination is key to reducing HBV

Area of Science:

  • Pediatric Hepatology
  • Virology
  • Public Health

Background:

  • Childhood hepatitis B virus (HBV) infection presents unique medical and public health challenges.
  • Infants infected perinatally have a high risk (up to 90%) of developing chronic HBV.
  • Many infected children are asymptomatic with normal liver enzymes, yet risk chronic liver disease or cancer.

Purpose of the Study:

  • To review aspects of hepatitis B virus infection unique to or different in children.
  • To discuss the evolving optimal treatment strategies for chronic HBV in pediatric populations.
  • To highlight the importance of vaccination in managing childhood HBV.

Main Methods:

  • Literature review of pediatric HBV infection.
  • Analysis of treatment options including interferon-alfa and lamivudine.
  • Evaluation of vaccination impact on HBV prevalence.

Main Results:

  • Chronic HBV infection in children often presents with minimal symptoms and normal liver enzymes.
  • Interferon-alfa and lamivudine are available treatments, but optimal use is still being determined.
  • Universal infant vaccination significantly reduces HBV infection rates and long-term complications.

Conclusions:

  • Childhood HBV infection requires specialized medical and public health approaches.
  • Understanding treatment indications, timing, efficacy, and side effects is crucial for pediatric HBV management.
  • Infant vaccination remains the most effective strategy for preventing childhood HBV infection and its sequelae.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...